Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated March 19, 2026, titled "Gaudium IVF and Women Health Limited Announces Q3 & 9M FY26 Financial Results".
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF announced its unaudited financial results for Q3 FY26 and the nine months ended December 31, 2025 — its first earnings release since listing on NSE and BSE on February 27, 2026 after an IPO that raised about ₹16,500 lakh. For Q3 FY26, revenue from operations stood at ₹2,450.70 lakh with a net profit of ₹363.05 lakh, while PBT was ₹496.31 lakh. For 9M FY26, revenue from operations reached ₹7,400.58 lakh and net profit came in at ₹1,614.90 lakh, with PBT of ₹2,174.59 lakh. The company said it maintained healthy margins supported by operating leverage and disciplined cost management. This is the first set of public quarterly numbers available to investors post-listing.
As the company's first reported quarter after its IPO, these numbers set the initial benchmark for newly listed shareholders — decent profitability and a clean first print, but no prior-year comparison is provided in the release, so investors will need to wait for the full filing to gauge actual growth trends.